High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival
about
sameAs
Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastomaStructure and ligand-induced conformational change of the 39-kDa glycoprotein from human articular chondrocytesA YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancersPotential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cellsYKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas.In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases.Increased expression and possible role of chitinase 3-like-1 in a colitis-associated carcinoma modelAnimal models of colitis-associated carcinogenesis.Expression of the chitinase family glycoprotein YKL-40 in undifferentiated, differentiated and trans-differentiated mesenchymal stem cells.Chitinase 3-like-1 expression in colonic epithelial cells as a potentially novel marker for colitis-associated neoplasia.YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional studyBreast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers.Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer.Gene-expression analysis of a colorectal cancer-specific discriminatory transcript set on formalin-fixed, paraffin-embedded (FFPE) tissue samples.Cells from the skin of patients with systemic sclerosis secrete chitinase 3-like protein 1.Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation.Stabilin-1, a homeostatic scavenger receptor with multiple functions.Is YKL-40 a new therapeutic target in cancer?Serum YKL-40 Levels in Patients with Gastric CancerHuman chitinases and chitinase-like proteins as indicators for inflammation and cancerYKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: RESULTS from the NORDIC VII StudyPlasma YKL-40: a potential new cancer biomarker?YKL-40: a new biomarker in cardiovascular disease?Are SMAD7 rs4939827 and CHI3L1 rs4950928 polymorphisms associated with colorectal cancer in Egyptian patients?YKL-40, a secreted glycoprotein, promotes tumor angiogenesisYKL-40 acts as an angiogenic factor to promote tumor angiogenesis.The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alphaYKL-40 expression could be a poor prognostic marker in the breast cancer tissue.CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells.Early detection of recurrence after curative resection for colorectal cancer - obstacles when using soluble biomarkers?Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells.A Heparin Binding Motif Rich in Arginine and Lysine is the Functional Domain of YKL-40.Increased CCL17 serum levels are associated with improved survival in advanced melanoma.Gene expression profiling in a mouse model of Helicobacter-induced gastric cancer.The Assessment of Clinical Usage and Prognostic Value of YKL-40 Serum Levels in Patients With Rectal Cancer Without Distant Metastasis.YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma.The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation.
P2860
Q24295370-6E0F137B-585E-42B6-97BA-7DFC29FCF551Q24303575-D77909AA-90D4-4E11-8F8F-F9F2B77E52E3Q24595527-D3CB81A6-467A-4DB3-8FD7-FCA2BD186918Q24656942-39D7D7C3-A765-4C20-A107-9A0B86EEBB93Q33719157-BAD66660-C5C4-464A-8051-1CC07394652AQ33942238-BD2CBC13-FCA8-4DED-891D-662CC25F4344Q34499108-A1ED00B9-164B-4BA0-9235-34AE88F5DCFFQ34512820-F347A87F-59AD-443C-97FF-B0819BFD5B38Q34720622-47FDE365-7B94-4B86-B789-10F1FB5591E0Q35168063-FA6309B6-E647-473F-83BC-7A7038572694Q35433475-273B022A-5515-4BCB-81C6-04FF1F081FC1Q35527112-D7D9AECA-ECCC-4512-A94F-FF49A96D725CQ35647254-FBB75DC1-0708-41A9-A9C4-67C64B169BF8Q35889007-160C3F3F-2E82-4666-9DBE-768AB4009A0EQ36250788-CA49896D-AC66-42D4-8D29-E32FB2E0E099Q36568996-DC223627-BBC1-445A-88E5-8C0F7F729E40Q36600426-7A41FE46-F374-4748-B432-D5F7D186D8B7Q36709555-63DDA5E8-AADB-4BCF-AA99-98C0E30B27A2Q37218917-AE0B113C-4443-4841-A4BE-F922CB1FEBF8Q37280948-3FB48BF0-BE11-4750-B59A-11712DBF9E33Q37334247-82AABB10-391A-41AE-B235-4DC8B2CA1EE6Q37548804-A92A7376-833C-467A-9815-188F3239CA62Q37605869-8FE29B9E-7BFE-4348-844D-5854284A85A6Q37779310-8C9F8F42-AEA2-4214-8996-CFFDA59C6363Q38852978-1AE375A7-0EF0-4B4F-899A-1CA899167AE3Q39797155-97E1F64C-8A6E-4465-9CBC-44F287E6B3D1Q41073254-1726E33B-B724-462E-B437-C9A426D1814CQ42050319-076F63F7-9C3C-489A-8131-4336A1473120Q42442642-91E43523-50F8-43EB-967E-9CD3E39D7DE2Q43053159-F4B11FBB-7838-404C-A6ED-BBC6680B662BQ44844409-54C150F6-E809-4641-B339-DB01D4329F04Q46383598-1268A8D0-EC2A-487C-AB2B-FB50B146EB3CQ47254535-0C8D03AE-5649-472B-9BE6-B9AEDB2438A8Q51023581-10319EFA-A09C-4507-9CDF-E44D2D3AEE9DQ51581930-B2736889-9461-4B90-9921-93D70FDD8665Q52593486-478C97A7-DA49-4DDD-92DD-57F3CAF32A63Q53204820-CC2A5F6A-FEA9-4A01-AEA5-4445A9640151Q53622506-5C07FA7C-69AB-4AC2-B389-F5F845C3A4DD
P2860
High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
High serum YKL-40 level after ...... a is related to short survival
@ast
High serum YKL-40 level after ...... a is related to short survival
@en
High serum YKL-40 level after ...... a is related to short survival
@nl
type
label
High serum YKL-40 level after ...... a is related to short survival
@ast
High serum YKL-40 level after ...... a is related to short survival
@en
High serum YKL-40 level after ...... a is related to short survival
@nl
prefLabel
High serum YKL-40 level after ...... a is related to short survival
@ast
High serum YKL-40 level after ...... a is related to short survival
@en
High serum YKL-40 level after ...... a is related to short survival
@nl
P2093
P2860
P356
P1433
P1476
High serum YKL-40 level after ...... a is related to short survival
@en
P2093
Christina Cintin
Ib Jarle Christensen
Julia S Johansen
Paul A Price
P2860
P304
P356
10.1002/CNCR.10644
P407
P577
2002-07-15T00:00:00Z